SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-123816
Filing Date
2023-12-06
Accepted
2023-12-06 07:46:18
Documents
14
Period of Report
2023-12-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2332239d1_8k.htm   iXBRL 8-K 27254
2 EXHIBIT 99.1 tm2332239d1_ex99-1.htm EX-99.1 19908
6 GRAPHIC tm2332239d1_ex99-1img11.jpg GRAPHIC 10773
  Complete submission text file 0001104659-23-123816.txt   244163

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ipsc-20231206.xsd EX-101.SCH 3018
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipsc-20231206_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipsc-20231206_pre.xml EX-101.PRE 22361
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2332239d1_8k_htm.xml XML 3428
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40498 | Film No.: 231468437
SIC: 2836 Biological Products, (No Diagnostic Substances)